Medpace Holdings, Inc. - Common Stock (MEDP)

Historical Holders from Q3 2016 to Q3 2025

Symbol
MEDP on Nasdaq
CUSIP
58506Q109
Type / Class
Equity / Common Stock
Shares outstanding
30.9M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
26.3M
Holdings value
$8.27B
% of all portfolios
0.012%
Grand Portfolio weight change
+0.001%
Number of holders
590
Number of buys
294
Number of sells
-276
Average Value change %
0%
Average buys %
+0.003%
Average sells %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Medpace Holdings, Inc. - Common Stock (MEDP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Troendle August J. 19.5% $1.7B 6.02M August J. Troendle Mar 7, 2025

Institutional Holders of Medpace Holdings, Inc. - Common Stock (MEDP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.57K $806K +$116K $514.40 2
2025 Q2 26.3M $8.27B +$320M $313.86 590
2025 Q1 25.3M $7.72B -$9.72M $304.69 576
2024 Q4 25.3M $8.42B +$79M $332.23 578
2024 Q3 25.1M $8.38B -$157M $333.80 576
2024 Q2 25.1M $10.3B +$74.3M $411.85 618
2024 Q1 25M $10.1B +$221M $404.15 584
2023 Q4 82.6K $25.4M +$11.3M $306.53 5
2023 Q3 23.8M $5.76B -$27.5M $242.13 477
2023 Q2 23.7M $5.69B -$272M $240.17 451
2023 Q1 24.9M $4.67B +$108M $188.05 408
2022 Q4 24.1M $5.13B -$275M $212.41 409
2022 Q3 25.7M $4.04B -$78M $157.17 334
2022 Q2 26.3M $3.93B -$150M $149.67 324
2022 Q1 27.3M $4.46B -$289M $163.59 331
2021 Q4 28.5M $6.2B -$16.4M $217.64 375
2021 Q3 28.6M $5.42B +$189M $189.28 330
2021 Q2 27.6M $4.87B -$59.8M $176.63 319
2021 Q1 28M $4.59B +$104M $164.05 313
2020 Q4 27.7M $3.85B +$92.4M $139.20 304
2020 Q3 26.9M $3B -$129M $111.75 302
2020 Q2 28.3M $2.64B +$18.3M $93.02 264
2020 Q1 28.1M $2.06B -$35M $73.38 260
2019 Q4 28.8M $2.42B +$12.9M $84.06 242
2019 Q3 28.5M $2.39B -$75.1M $84.04 258
2019 Q2 29.7M $1.92B +$236M $65.42 216
2019 Q1 27.1M $1.6B -$95.6M $58.97 224
2018 Q4 28.6M $1.51B +$237M $52.93 211
2018 Q3 24.1M $1.44B +$617M $59.91 205
2018 Q2 13.9M $598M +$190M $43.00 141
2018 Q1 9.42M $329M +$38.1M $34.91 108
2017 Q4 8.57M $303M +$73.4M $36.26 111
2017 Q3 6.39M $204M +$6.86M $31.90 84
2017 Q2 6.31M $183M -$11M $29.00 76
2017 Q1 6.62M $198M -$7.56M $29.85 76
2016 Q4 7.26M $262M +$49M $36.07 78
2016 Q3 6.17M $180M +$180M $29.86 68